C00-C97
Conditions
Interventions
Group 1: 1-armed observational trial. Patients presenting at the UCCH survivorship consultation report their psychosocial distress and requirement of support via questionnaire (DT, SCNS-SF34, PHQ-9, G
sex
primary diagnosis: lymphoma, leukemia, gastrointestinal, gynecological, sarcoma, other
treatment modality: multimodal, local, systemic
time sinde diagnosis: 0-2, 3-5, 6-10, 10+ years).
Sponsors
Universitätsklinikum Hamburg-Eppendorf
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with a history of cancer diagnosis who are undergoing follow-up and are currently tumor-free, patients who have completed tumor therapy or are in long-term maintenance therapy, age = 18 years, provided written informed consent.
Exclusion criteria
Exclusion criteria: Patients with a cancer diagnosis and are currently undergoing therapy, age < 18 years, or did not provide written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impact of time since diagnosis on self-reported distress/anxiety/depression/fatigue. | — |
Secondary
| Measure | Time frame |
|---|---|
| Impact of treatment modality/cancer diagnosis group/age on self-reported distress (NCCN DT), requirement of support (SCNS SF), anxiety (GAD-7), depression (PHQ-9) and fatigue (FACIT). The assessment of the questionnaires will be conducted within the survivorship councelling (week 0) and another time postal (week 24). | — |
Countries
Germany
Contacts
Public ContactJannike Salchow
Universitätsklinikum Hamburg-Eppendorf
Outcome results
None listed